Lv14
80 积分 2025-04-17 加入
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
6小时前
待确认
What Is Multiple Myeloma?
2天前
已完结
Multiple myeloma
2天前
已完结
Efficacy and Safety of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed and/or Refractory Multiple Myeloma: Pooled Analysis of 2 Single Arm Studies
10天前
已完结
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options
25天前
已完结
Relapsed refractory multiple myeloma: a comprehensive overview
25天前
已完结
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
25天前
已完结
The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies
25天前
已完结
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
29天前
已完结
Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma
1个月前
已完结
皖公网安备34019202002308
